Zhang R - Search Results

1

[Quantitative analysis for JAK2 mutation in 98 patients with essential thrombocythemia and its clinical significance].

Chao HY, Shen YM, Zhang R, Feng YF, Cen JN, Yao L, Shen HJ, Zhu ZL, Xue YQ. Chao HY, et al. Among authors: zhang r. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):665-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19549384 Chinese.

2

[Down-regulation of expression of vascular endothelial growth factor induced by arsenic trioxide in bone marrow cells of chronic myeloid leukemia].

Li L, Zhang R, Zhu ZL. Li L, et al. Among authors: zhang r. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Jun;11(3):263-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003. PMID: 12844409 Chinese.

3

[Combined analysis on morphology, immunology, cytogenetics and molecular biology (MICM) classification of 55 patients with acute promyelocytic leukemia].

Xiao R, Zhang R. Xiao R, et al. Among authors: zhang r. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Apr;12(2):147-50. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15157321 Chinese.

4

[The mechanism of arsenic trioxide-inducing apoptosis of K562 cells].

Zhang XH, Zhang R, Zhu ZL, Wang W. Zhang XH, et al. Among authors: zhang r. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Oct;12(5):558-62. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15498110 Chinese.

5

[Interdigitating dendritic cell sarcoma-a case report with literature review].

Gao WJ, Zhang R, Qiu HX, Shen YM, Zhang XH, Xue SL, Han Y. Gao WJ, et al. Among authors: zhang r, zhang xh. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):232-4. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 15949268 Review. Chinese.

6

[Expression of soluble GM-CSF-Ralpha in patients with acute myeloid leukemia].

Xiao R, Zhang R, Wang YL, Zhu ZL, Chen T, Yang JH. Xiao R, et al. Among authors: zhang r. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):225-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16638185 Chinese.

7

Analysis of JAK2(V617F) mutation in Chinese patients with myeloproliferative disorders.

Chen S, Fei H, Zhang R, Xue Y, Pan J, Wu Y, Ceng J. Chen S, et al. Among authors: zhang r. Am J Hematol. 2007 Jun;82(6):458-9. doi: 10.1002/ajh.20872. Am J Hematol. 2007. PMID: 17266061 Free article.

8

[The clinical implication of JAK2 mutation expression in patients with myeloproliferative disorders].

Fei HR, Zhang R, Chen SN, Pan JL, Cen JN, Xue YQ. Fei HR, et al. Among authors: zhang r. Zhonghua Nei Ke Za Zhi. 2007 Apr;46(4):271-3. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17637260 Chinese.

9

[Expression of JAK2V617F and MPLW515L/K mutation in 30 suspected cases of early myeloproliferative disorders].

Fan Z, Zhang R, Shen YM, Fei HR, Zhu ZL, Cen JN. Fan Z, et al. Among authors: zhang r. Zhonghua Xue Ye Xue Za Zhi. 2008 Sep;29(9):611-4. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 19175989 Chinese.

10

[The quantitative assay and clinical significance of JAK2V617F mutation in 131 patients with chronic myeloproliferative disorders].

Shen YM, Chao HY, Zhang R, Feng YF, Cen JN, Yao L, Shen HJ, Zhu ZL, Xue YQ. Shen YM, et al. Among authors: zhang r. Zhonghua Nei Ke Za Zhi. 2009 Feb;48(2):140-3. Zhonghua Nei Ke Za Zhi. 2009. PMID: 19549471 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,892 results

Search Page

Filters